This article was originally published in The Tan Sheet
Rogaine third quarter U.S. sales reached $24 mil., a 25% decline, and $32 mil. worldwide, down 18% from the year-ago period, company reports Oct. 30. Pharmacia's marketing exclusivity for the hair regrowth formula expires Nov. 14; Perrigo recently postponed launch of its private label minoxidil 5% (1"The Tan Sheet" Oct. 30. p. 13). Revenue from U.S. sales of Nicorette reached $21 mil. in the quarter, up 5%, with flat worldwide sales of $50 mil. Pharmacia recently acquired the Nicotrol smoking cessation brand from McNeil (2"The Tan Sheet" Oct. 23, p. 6). Pharmacia net sales totaled $4.3 bil. in the quarter, up 15%, with net earnings up 61% to $427 mil
You may also be interested in...
Corrective actions taken in response to an unfavorable FDA inspection of Perrigo's Allegan, Mich. facility will preclude the planned November launch of minoxidil 5% and stall the company's pipeline, Perrigo told analysts in an Oct. 25 conference call.
J&J/Merck's Pepcid Complete is the first OTC stomach remedy to combine a fast-acting antacid ingredient with a long-term acid control ingredient, according to the firm. FDA approved NDA 20-958 for Pepcid Complete Oct. 16.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC